MedMira signs HIV test distributor in Middle East:
This article was originally published in Clinica
Executive Summary
MedMira, the Halifax, Canada-based in vitro rapid test maker, has signed a distribution deal in the Middle East for MiraWell rapid HIV Test. Abu Dhabi's Prestige Group will distribute the product to the hospital and healthcare facilities in the region once it has received regulatory approval, expected in the next couple of months. The World Health Organization estimates that there were 83,000 new cases of HIV infection in the Middle East in 2003. MedMira's product is designed for serum, plasma or whole blood testing.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.